Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: A retrospective and prospective study

British Journal of Dermatology

Volumn 162, Issue 2, 2010, Pages 445-447

  Andres, C ^a   Kollmar, A ^a   Mempel, M ^a   Hein, R ^a   Ring, J ^a   Eberlein, B ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

7 5 MHz ultrasound; Collagen metabolism; Cutometer; Localized scleroderma; Ultraviolet A1

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; CREATININE; DEOXYPYRIDINOLINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED STUDY; ELASTICITY; FEMALE; HUMAN; LOCALIZED SCLERODERMA; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; QUESTIONNAIRE; RADIATION DOSE; RATING SCALE; SKIN DEFECT; SKINFOLD THICKNESS; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION;

ADULT; AGED; COLLAGEN; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SCLERODERMA, LOCALIZED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY;

EID: 74349104968     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09438.x     Document Type: Article

References (14)

1. Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc 1995 70 : 1068 1076.
2. Kreuter A, Hyun J, Stücker M et al. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 2006 54 : 440 447.
3. Czirjak L, Nagy Z, Aringer M et al. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis 2007 66 : 966 969.
4. Enomoto DN, Mekkes JR, Bossuyt PM et al. Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma. J Am Acad Dermatol 1996 35 : 381 387.
5. Stege H, Berneburg M, Humke S et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997 36 : 938 944.
6. Morita A, Kobayashi K, Isomura I et al. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol 2000 43 : 670 674.
7. Wang F, Garza LA, Cho S et al. Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy. Arch Dermatol 2008 144 : 851 858.
8. Sator PG, Radakovic S, Schulmeister K et al. Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment. J Am Acad Dermatol 2009 60 : 786 791.
9. Jacobe HT, Cayce R, Nguyen J. UVA1 phototherapy is effective in darker skin: a review of 101 patients of Fitzpatrick skin types I-V. Br J Dermatol 2008 159 : 691 696.
10. Kratofiel M, Pöschel B, Kohl PK. Evaluation of psoralen plus ultraviolet-A bath therapy for sclerosing dermatoses by in vivo measurement of skin elasticity using Cutometer SEM 575. In : Skin Cancer and UV Radiation (Altmeyer P, Hoffmann K, Stücker M, eds). Heidelberg : Springer-Verlag, 1997 442 445.
11. de Rie MA, Enomoto DN, de Vries HJ et al. Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the Cutometer and fast Fourier transform method. Dermatology 2003 207 : 298 301.
12. Gruss C, Reed JA, Altmeyer P et al. Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet 1997 350 : 1295 1296.
13. Stege H, Schopf E, Ruzicka T et al. High-dose UVA1 for urticaria pigmentosa. Lancet 1996 347 : 64.
14. Mempel M, Schmidt T, Boeck K et al. Changes in collagen I and collagen III metabolism in patients with generalized atopic eczema undergoing medium-dose ultraviolet A1 phototherapy. Br J Dermatol 2000 142 : 473 480.